NICE is assessing siponimod for secondary progressive MS (SPMS) to decide whether it should be prescribed by the NHS in England and Wales. Scotland and Northern Ireland will carry out separate appraisals.
The MS Trust will be explaining to NICE why we think siponimod should be made available on the NHS. To help us make a strong case, we want to hear your experiences of living with SPMS, your views on current NHS care for SPMS and your thoughts on siponimod.
We’d like to hear from you if you live in the UK and
- you have secondary progressive MS
- you have a different type of MS, but would like to add your views
- you are a partner / friend / relative / carer of someone with SPMS
- you are a health professional providing care for people with SPMS
Tell us what you think by completing this short questionnaire by 17 September.
Does a sense of humour help when you're living with MS?
30/06/2022 - 00:00
Nigel Bartram was diagnosed with multiple sclerosis 13 years ago. In his new book MS A Funny Thing (well s😊metimes), he looks at some of the more comedic elements of living with a chronic illness.
Updated NICE multiple sclerosis guideline contains some good news and some bad news
22/06/2022 - 00:00
There are some positive points in the revised 2022 guideline but the MS Trust is disappointed that NICE has been unable to recommend Fampyra.
Connors letter to MS
21/06/2022 - 00:00
In 2022, Connor will be taking part in the Great North Run to support the MS Trust. Here, Connor writes a letter to MS, openly sharing his thoughts on the condition his sister was diagnosed with at the age of 14.
Sign up for updates from us
Keep up-to-date with the latest MS news, explore new research, read the stories of people living with MS, find out practical tips from MS experts, and discover exciting fundraising opportunities.